Are data availability statements slowing down publication processes?
Read the results of a pilot study on the impact of data availability statements on publication workflows.
A central online news resource for professionals involved in the development of medical publications and involved in publication planning and medical writing.
Read the results of a pilot study on the impact of data availability statements on publication workflows.
Read about their call to action for the pharmaceutical industry to increase sharing of clinical trial data.
A new study looks at why researchers may question their past conclusions and how likely they are to disclose this publicly.
Nature analyses the ongoing battle publishers are facing against paper mills and what editors are doing to identify these fake articles.
European countries can’t agree on what counts as research misconduct, creating potential pitfalls for researchers.
Read Suzanne Farley’s perspectives on the steps one publisher is taking to address the growing problem of research misconduct.
The third webinar in the Biomedical Transparency Summit Series considered the impact of COVID-19 on research transparency and data sharing.
Read Ivan Oransky’s take on the retraction landscape and his perspectives on how to tackle research integrity issues in the future.
Find out more about what was covered during the first 2021 webinar from the Center for Biomedical Research Transparency.
Find out how principles of research integrity can be put into practice to combat fraud and misconduct.
Two articles explore how the use of metrics has enabled the evolution of new types of scientific fraud, including citation manipulation.